8VC

Activity from announced rounds

Activity in this selectionOct 16, 2026 · Sep 17, 2026
Rounds participated in
3
Confirmed lead rounds
0
All roles disclosed
New companies
2
First participation on record · 1 follow-on
Funding in participating rounds
$370.5M
3 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1
Series C+1

By primary sector

AI1
Biotech1
Cybersecurity1

By country

United States3

Rounds

3 in this selection
Armadin

Armadin develops AI agents that test attack paths across enterprise systems and show defenders how connected weaknesses could be exploited.

$255.5MSeries B
Participant
BigHat Biosciences

An AI and synthetic-biology platform that designs and engineers antibody therapeutics.

$75MSeries C
Participant
Vals AI

Vals AI evaluates AI models on multi-step, economically valuable work across fields such as legal analysis, financial modeling and software engineering. Its private task-specific benchmarks, expert review and developer integrations help companies measure real-world capability and production risks.

$40MSeries A
Participant